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Abstract Recently mutations in the LGI1 (leucine-rich, glioma-
inactivated 1) gene have been found in human temporal lobe
epilepsy. We have now identified three formerly unknown LGI-
like genes. Hydropathy plots and pattern analysis showed that
LGI genes encode proteins with large extra- and intracellular
domains connected by a single transmembrane region. Sequence
analysis demonstrated that LGI1, LGI2, LGI3, and LGI4
form a distinct subfamily when compared to other leucine-rich
repeat-containing proteins. In silico mapping and radiation
hybrid experiments assigned LGI2, LGI3, and LGI4 to differ-
ent chromosomal regions (4p15.2, 8p21.3, 19q13.11), some of
which have been implicated in epileptogenesis and/or tumori-
genesis. . 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Mutations in the LGI1 gene (leucine-rich, glioma-inacti-
vated 1) were recently found in families with autosomal dom-
inant lateral temporal lobe epilepsy (ADLTE) [1], a rare idi-
opathic partial epilepsy syndrome. LGI1 encodes a putative
membrane-anchored protein of unknown function, which is
characterized by a leucine-rich repeat (LRR) domain £anked
by conserved cysteine clusters. LGI1 has been cloned from the
t(10:19) balanced translocation breakpoint in a glioblastoma
cell line, and was therefore named according to its possible
function as a tumor-suppressor gene. The possible role in
tumorigenesis was further supported by the observation of
LGI1 down-regulation in malignant gliomas [2]. Thus it
came as a surprise that LGI1 is associated with epilepsy in
several families not known for an unusual accumulation of
brain tumors or other malignancies [1]. So far all genes known
to be mutated in human idiopathic epilepsies were encoding
ion channels [3]. Other genes, like the gene encoding the anti-
convulsant peptide dynorphin, are associated with an in-
creased risk for convulsions, but cannot cause epilepsy by
themselves [4]. LGI1 presented the ¢rst evidence that genes
not encoding ion channels can be mutated in these common
neurological disorders. Genes that are functionally or struc-
turally related to LGI1 now have to be regarded as candidates
for di¡erent epilepsies. We therefore used a combined in sil-
ico- and bench-cloning approach to search for sequences with
high similarities to LGI1 and identi¢ed three formerly un-
known genes named LGI2, LGI3, and LGI4. Comparison
of predicted protein sequences and structures showed that
the four LGI genes belong to a formerly unknown subfamily
within the superfamily of LRR proteins. We describe the
cDNA and deduced amino acid sequences, as well as di¡er-
ences in mRNA expression patterns for the human (h) LGI1^
LGI4 genes. Furthermore, we examine the phylogenetic origin
and present chromosomal assignments for hLGI and murine
LGI genes.
2. Materials and methods
2.1. Database search and sequence computation
To identify hLGI sequences a translated basic local alignment
search tool nucleotide (tBLASTn) search with the known hLGI1 pep-
tide sequence (NM005097) was carried out using the NCBI human
expressed sequence tag (EST) database (http://www.ncbi.nlm.nih.
gov). The genomic sequences containing cDNA fragments were re-
trieved by basic local alignment tool (BLAT) search from the Human
Genome Project Working Draft database (HGWD) (http://www.
genome.ucsc.edu) (hLGI2, hLGI4) and by BLASTN search from hu-
man genomic sequence sca¡olds and unordered pieces in the Celera
Genomics database (http://www.celera.com) (hLGI3). The hLGI
sequences were used to retrieve mouse LGI (mLGI) sequences
from both databases. EST contig building and sequence alignment
was carried out using the Heidelberg Unix Sequence Analysis Re-
sources (HUSAR) DNA analysis package (http://genius.embnet.
dkfz-heidelberg.de).
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2.2. RT-PCR, genomic PCR and cDNA ampli¢cation
To clone the complete reading frames of hLGI genes, RT-PCR was
performed using the Titan RT-PCR kit (Roche Molecular Biochem-
icals, Mannheim, Germany) according to the manufacturer’s manual.
For veri¢cation of the intron^exon boundaries PCR reactions were
performed with genomic control DNA as template, which was pre-
pared from the blood of a healthy German individual. The PCR
pro¢le consisted of an initial 3 min at 95‡C, followed by 35 cycles
of 30 s at 94‡C, 30 s at 55‡C, and 30 s at 72‡C, with a ¢nal incubation
of 10 min at 72‡C. Ampli¢ed products were sequenced using an ABI
Prism 377 automated DNA sequencer (Applied Biosystems, Foster
City, CA, USA). The distribution of hLGI mRNA expression was
analyzed using the Multiple Tissue cDNA Panel (Clontech, Palo
Alto, CA, USA). The ampli¢cation protocol included an initial dena-
turation step (94‡C, 3 min), followed by 35 cycles of ampli¢cation
(94‡C, 30 s; 55‡C, 30 s; 72‡C, 30 s) and a ¢nal extension step
(72‡C, 5 min).
2.3. Radiation hybrid mapping
For chromosomal assignment of hLGI2, hLGI3, and hLGI4 gene
speci¢c ampli¢cation from the GenBridge 4 radiation hybrid panel
was performed. Primer pairs are given in the legend to Fig. 1.
2.4. Immunohistochemical visualization of LGI1 in the human cortex
Brain specimens were obtained upon autopsy from control individ-
uals who were unknown to be a¡ected by neurological diseases during
life. Furthermore, the brains of all individuals studied were free of
apparent neuropathological changes, like amyloid plaques, neuro¢-
brillary tangles, vascular lesions, or obvious structural abnormalities.
Immunohistological staining was performed on 10 Wm cryostat sec-
tions from the frontal cortex of a 38-year-old male and a 44-year-old
female as well as on 7 Wm para⁄n sections from the temporal cortex
(¢ve individuals, age range 10^59 years, three males, two females).
Cryostat sections were incubated either with a commercially available
goat antiserum (10 Wg/ml) raised against a peptide mapping at the
amino-terminus of LGI1 (N-18, sc-9581, Santa Cruz, CA, USA) or
with a rabbit antiserum speci¢c for LGI1 (gift of J. Cowell) diluted
1:200, whereas para⁄n sections were incubated with the rabbit anti-
serum diluted 1:50. Incubations with the primary antibodies were
carried out overnight at 4‡C. Visualization of antibody binding was
achieved by a biotinylated secondary antibody and a streptavidin^
peroxidase complex (ABC technique) using the chromogen diamino-
benzidine according to standard protocols. In case of para⁄n sections
pretreatment with 0.05% trypsin (pH 7.8, 20 min, 37‡C) was manda-
tory prior to the application of rabbit antiserum. For control pur-
poses, the working dilution of sc-9581P antiserum was preincubated
with its peptide (50 ng and 100 ng, sc-9581, Santa Cruz) prior to
application.
3. Results
3.1. Cloning of LGI2, LGI3, and LGI4
The tBLASTn search identi¢ed di¡erent human EST frag-
ments, which encoded peptides with high similarity to parts of
LGI1. RT-PCR was performed to verify the in silico-cloned
sequences and to ¢ll in the gaps. The cDNA sequences of
three novel genes, containing the intact open reading frames,
could thus be identi¢ed. The genes were named LGI2, LGI3,
and LGI4, their sequences were submitted to GenBank
(http://www.ncbi.nlm.nih.gov/GenBank) (accession numbers:
AF467954^AF467956). The sequences of the four mLGI genes
were determined in silico.
3.2. Sequence comparison
hLGI2, hLGI3 and hLGI4 encode predicted proteins of
545, 549, and 538 amino acid residues, respectively. Fig. 2
shows the alignment of the four proteins. Hydropathy calcu-
lation (MacMolly Tetra Lite, Soft Gene, Berlin, Germany)
indicated a signal peptide at the N-terminus and a putative
transmembrane region at a position conserved among all LGI
peptides (Fig. 2). Human and murine LGI peptides have iden-
tical overall structures, with four complete and one partial
LRR in the putative extracellular part. Cysteine-rich regions
£ank the LRRs on both the N-terminal and the C-terminal
side, the N-terminal region showing the conserved cysteine
motif CX3CXCX6C [5,6]. Such cysteine-consensus £anks are
characteristic for most extracellular LRR proteins. With the
exception of the third LRR of LGI4, all LGI LRRs have the
conserved phenylalanine at position 20 and thus belong to the
so-called ‘F-20’ family of LRR, which also includes proteins
like slit, biglycan and osteomodulin [6]. The predicted intra-
cellular parts of the four LGI peptides were highly similar to
each other, no known sequence motifs could be identi¢ed for
either LGI peptide. For each of the LGI peptides the intra-
cellular part contained several di¡erent putative phosphoryla-
tion site consensus sequences, some of them were conserved
within the subfamily (Fig. 2). The high degree of similarity
among the LGI peptides is not only present in the LRR re-
peats, but was found through the entire length of the peptides.
The extracellular parts of the peptides share 61^72% similarity
with each other, the intracellular parts 62^72%. The trans-
membrane domain represents the most conserved region of
the peptides, with 75^99% similarity among the di¡erent
LGI members. The overall similarity between the mLGI and
hLGI genes was 97% for LGI1, 98% for LGI2, 97% for LGI3,
and 93% for LGI4.
3.3. Gene structure
The genomic organizations of the new hLGI and murine
LGI genes were deduced from the alignment of their cDNA
sequences with the corresponding genomic fragments. The
positions of intron^exon boundaries in hLGI1 and hLGI4
Fig. 1. hLGI1^hLGI4 mRNA expression patterns. Semi-quantitative
PCR was carried out using the following primer pairs: hLGI1,
5P-ATTTTCCTTGAATGGGACCATGTGG-3P, 5P-TGAGGCGTT-
CTGAGTGTCTGAGGT-3P ; hLGI2, 5P-TTTGTCATCGCAGACA-
GCTC-3P, 5P-AAGCGGGTAAGGGAAAGGTA-3P ; hLGI3, 5P-CT-
GTTTGGCGGCTCTTACAT-3P, 5P-GAGCTGCTGGACACAATC-
AG-3P ; hLGI4, 5P-GAAGGGCAACCCTGCTTC-3P, 5P-ATGTAG-
CGTGTGAGGCACAG-3P. GADPH primers were used to allow
for normalization of RNA concentration. Lane 1, heart; lane 2,
brain; lane 3, placenta; lane 4, lung; lane 5, liver; lane 6, muscle;
lane 7, kidney; lane 8, pancreas. The hLGI2, hLGI3, and hLGI4
primers given here were also used for radiation hybrid mapping.
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were experimentally veri¢ed by PCR ampli¢cation of genomic
DNA. As shown in Fig. 2, seven introns are inserted at strictly
conserved positions in all four LGI genes. The same intron
positions were found in the respective murine genes (data not
shown). The ¢rst ¢ve introns are inserted between the second
and third nucleotides of the codons for leucine or valine found
in the ¢fth amino acid position of each LRR repeat. Except
for these seven introns that are conserved between all four
genes, LGI4 has an extra intron within the C-terminal part,
located between codons M433 and V434.
3.4. Genomic localizations of LGI genes
By running a BLAT search of cDNA sequences against the
December 22, 2001 draft assembly of the HGWD database,
cytogenetic positions were derived for hLGI1 (10q23.33),
hLGI2 (4p15.2), and hLGI4 (19q13.11). Radiation hybrid
mapping results were compatible with these predictions (Table
1), and helped to assign the hLGI3 sequence, which was not
found in the HGWD database (8p21.3). The murine LGI
genes were located on mouse chromosomes 19, 5, 14 and 7,
respectively, in subregions synthenic to the localization of the
corresponding human genes.
3.5. mRNA expression patterns
The distribution patterns of hLGI mRNA expression in
di¡erent tissues were studied by semi-quantitative PCR with
cDNA from eight di¡erent tissues as templates (Fig. 1). Both
hLGI1 and hLGI4 are expressed in all tissues studied, and
their expression was apparently highest in brain. hLGI2
mRNA could only be detected in brain, heart, and placenta.
PCR from these cDNA samples gave rather weak bands.
hLGI3 was present in all tissues, but the signals from brain
and lung were apparently stronger than those from other tis-
sues (Fig. 1). However, in semi-quantitative PCR the di¡er-
ences in signal intensity might not correlate directly to the
amount of mRNA present in the respective tissue.
3.6. LGI1 protein expression in human brain
Immunohistological experiments demonstrated that the
hLGI1 mRNA is translated into protein. LGI1-immunoreac-
tive neurons were found in all layers of the frontal (Fig. 3)
and temporal (Fig. 4) cortex with strongest labeling intensities
in layers II/III. Most of the labeled neurons displayed a py-
ramidal shape. The immunoprecipitate was located within the
perikaryon sparing the nucleus and sometimes extending into
Fig. 2. Alignment of deduced amino acid sequences of hLGI1, hLGI2, hLGI3 and hLGI4. Shaded boxes indicate the shared amino acid se-
quence identity between at least three genes. Stars indicate conserved cysteine residues, the LRR-containing regions are marked by a single line
(LRRs are separated by vertical bars), and a double line indicates the regions predicted to contain the transmembrane domain. Dots indicate
amino acids not found in one or more LGI genes. The positions of introns in the genomic sequence are marked by inverted triangles (¢lled tri-
angles, introns shared by all four genes; open triangle, intron only found in LGI4). The numbers refer to amino acid residues in the LGI1 pro-
tein sequence. An asterisk indicates stop codons. Potential glycosylation sites found in at least three LGI genes are marked by half moons
(¢lled half moon, casein kinase II phosphorylation site; open half moon, protein kinase C phosphorylation site).
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the apical (Figs. 3D and 4) and, in rare cases, also into the
basal dendrites (Fig. 4A). The distribution pattern of immu-
noreactive cells was similar in all cortices investigated, how-
ever, the labeling intensity showed slight variations. Control
sections preincubated with the sc-9581 peptide did not show
any immunoreactive cells (Fig. 3B).
4. Discussion
Combining bioinformatics with con¢rmatory cloning and
sequencing, we found three novel genes, LGI2, LGI3, and
LGI4, homologous to LGI1. All four genes encode proteins
consisting of an extracellular domain containing an LRR re-
gion £anked by conserved cysteine clusters, a putative trans-
membrane region, and an intracellular domain without ob-
vious structural elements. Three di¡erent conserved patterns
of £anking cysteine clusters are found in most extracellular
LRR proteins. The conserved spacing of the N-terminal cys-
teine cluster, CX3CXCX6C, is present in all four LGI proteins
as well as in class I small leucine-rich proteoglycans (SLRP).
Except for the conserved cysteine cluster, the LGI proteins
showed no signi¢cant similarity to class I SLRPs like decorin.
The phylogenetic analysis (Fig. 5) showed that the four hLGI
peptides and their murine counterparts are closely related to
each other, while proteins showing di¡erent types of con-
served cysteine clusters [5] were placed more distantly on the
evolutionary scale. The branching pattern of the dendrogram
presented here (Fig. 5) strongly suggests that the four LGI
proteins belong to a formerly unknown subfamily of LRR
proteins.
Northern blot experiments detected hLGI1 expression only
in brain and skeletal muscle [2]. Using the more sensitive PCR
method we were able to show that hLGI1 mRNA can be
found in several other tissues. The observed expression pat-
terns of hLGI1 and hLGI4 mRNA are largely identical.
hLGI2 expression was only found in three of the tissues in-
vestigated here, while for hLGI3 at least faint bands were
detected in all other tissues. None of the tissues showed ex-
pression of only one LGI gene, and some tissues like heart,
brain and placenta even expressed all four di¡erent mRNAs.
A survey of LRR proteins suggests that the major function of
the LRRs may be to provide a structural framework for the
formation of protein^protein interactions [7]. Thus, provided
that the mRNAs detected here are indeed translated into pro-
tein, it will be interesting to see if the observed co-expression
re£ects related functions and if the LGI proteins are able to
associate with each other.
LGI1 is so far the only LGI gene found to be associated
with a human disorder. Previous publications have already
shown that LGI1 mRNA can be detected in di¡erent parts
of the brain, but the presence of the LGI1 protein in the
human brain has not been con¢rmed yet. We now demon-
strated that hLGI1 protein could indeed be found in the hu-
man temporal lobe, the part of the brain which probably
plays the most critical role in the generation of seizures in
ADLTE patients. The hLGI1 protein was mainly found in
Table 1
Radiation hybrid mapping of LGI genes
Gene
symbol
Primer paira
(product size)
Data vectorb Cytogenetic
map
localization
Genetic map
interval
GeneMap 99
Whitehead framework
physical map location
Whitehead map
£anking markers
hLGI2 LGI2for/rev
(299 bp)
01000001110010001100001101001000
10000100001011100011000010001100
01100000000000110110001000010
4p15.2 chromosome 4 6.3 cR from
D4S1021
D4S863
36.5 cM ^ SGC30299
^ 2.3 cR from
WI-6539
^
38.3 cM AFMB355YA5
SGC34745
hLGI3 LGI3for/rev
(292 bp)
00000000011000000010100000001100
00000110110111000100011001000100
00011110010010000002010101000
8p21.3 chromosome 8 4.7 cR from
WI-4688
WI-17471
42.2 cM ^ WI-4688
^ 2.8 cR from
WI-6536
^
44.9 cM WI-6304
WI-6536
hLGI4 LGI4for/rev
(312 bp)
00010001010010000000001111011101
00000010110011101010000010000110
01001111011001011100010000111
19q13.11 chromosome 19 9.7 cR from
CHLC.GATA10A05.799
SGC33351
58.1 cM ^ WI-16546
^ 7.3 cR from D19S224 ^
58.7 cM WI-15149
D19S224
By physical mapping using the GenBridge 4 radiation hybrid mapping panel, LGI genes were mapped with respect to Whitehead framework
markers (http://carbon.wi.mit.edu:8000/cgi-bin/contig/rhmapper.pl). Using markers £anking the genes on the Whitehead map, the position in an
interval of the GeneMap 99 (http://www.ncbi.nlm.nih.gov/genemap/) and in a cytogenetic interval (http://genome.cse.ucsc.edu/goldenPath/
hgTracks.html) were derived. In addition to the physical distance to the £anking Whitehead framework markers, for each of the genes the clos-
est £anking markers within the Whitehead RH map, the genetic map intervals according to GeneMap 99, and the cytogenetic position are
listed.
aPrimer pairs for hLGI2, hLGI3, hLGI4: see legend to Fig. 3.
b0, negative; 1, positive; 2, uncertain data.
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pyramidal neurons located in lamina II^III, but contrary to its
name, no apparent hLGI1 expression was seen in glial cells.
The immunohistological approach used here would also be
useful to study the precise anatomical distribution of LGI1
protein and its role in epileptogenesis.
Besides the involvement in epileptogenesis LGI1 is sus-
pected to act as a tumor-suppressor gene. It was therefore
interesting to see if the homologous genes hLGI2^hLGI4 are
located in candidate regions for epilepsy genes or in regions
showing loss of heterozygosity. Allelic losses of the short arm
of chromosome 4 are frequently found in several tumor types,
and the region 4p15.1^3 containing hLGI2 is suspected to
contain one or more tumor-suppressor genes [8^10]. Fine
mapping studies are not available yet, so it remains unclear
if hLGI2 is indeed located within the region of common dele-
tion. Various types of seizures and EEG abnormalities fre-
quently occur in patients with the 4p-syndrome (also named
Wolf^Hirschhorn syndrome), but hLGI2 is located outside the
critical region that is associated with most of the pattern of
the syndrome [11]. The chromosomal region containing
hLGI3, 8p21.3, was found to be associated with di¡erent tu-
mor types [12], but is not known as a candidate region for
unknown epilepsy genes, yet. Loss of heterozygosity of chro-
mosome 19q is a frequent event in di¡erent tumor types, but
at least in gliomas hLGI4 seems to be located outside the
region of common deletion [13^15]. hLGI4 can be considered
as a candidate gene for benign familial infantile convulsions, a
rare type of idiopathic epilepsy for which a gene had been
previously mapped to 19q13 [16].
So far the functional properties of LGI proteins remain
unknown. Since all other genes known to cause idiopathic
human epilepsies are encoding ion channels [3] the possibility
exists that LGI1 interacts with an unknown channel protein.
Thus it would be interesting to evaluate the possibility of LGI
Fig. 3. hLGI1 immunohistochemistry in human frontal cortex. In
cryostat sections, the staining and distribution pattern of hLGI1-im-
munoreactive cells obtained after incubation with sc-9581 goat anti-
serum (A) and the rabbit antiserum (C,D), respectively, was similar
as shown here for layers II/III of the frontal cortex. The immuno-
precipitate was located in the perikaryon sparing the nucleus
(A,C,D), sometimes extending into the apical dendrites (D). Note
that there was no signal in sections treated with pre-adsorbed
sc-9581 goat antiserum (B). Bars: 70 Wm.
Fig. 4. LGI1 immunohistochemistry in human temporal cortex. Lo-
calization of hLGI1-immunoreactive neurons in layers II/III of the
temporal cortex of a 27-year-old male (A) and of an 11-year-old fe-
male (B) neuropathological healthy individual. In particular the py-
ramidal-shaped neurons were intensely labeled. Bars: 70 Wm.
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proteins acting as accessory subunits for ion channels. Eluci-
dation of the biochemical and physiological features of the
di¡erent members of this new subfamily of LRR proteins
should lead to further understanding of the biological func-
tions of LGI proteins and their role in epileptogenesis. Fur-
thermore, it should help to clarify the question if members of
this new subfamily of LRR genes are indeed involved in tu-
morigenesis [2,17]. The latter could have serious implications
for families with LGI-associated epilepsies.
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